- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06247124
OPERATION WIPE OUT: Multi-Channel Communication Campaign to Promote HPV Vaccination in Chambers County, Alabama
March 13, 2024 updated by: Isabel Scarinci, University of Alabama at Birmingham
The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination for all children and adults ages 9 to 26 in the U.S.
However, HPV vaccination rates nationally and in Alabama lag far behind the Healthy People 2020 goal of 80% coverage.
Despite multiple efforts, Alabama still ranks third in cervical cancer mortality and incidence nationally with great disparities within the state, particularly between urban and rural counties.
In order to address this public health challenge, organizations have come together to develop, implement, and evaluate a statewide action plan to eliminate cervical cancer as a public health problem in Alabama by 2033.
This plan was officially launched by the State Health Officer in May 2023 as a partnership between government, academia, civic organizations, and non-profit organizations and is known as OPERATION WIPE OUT.
The overall goal of this Supplement is to develop, implement, and examine the feasibility and scalability of a theory-driven, participatory multi-channel communication campaign to promote HPV vaccination uptake that is designed and delivered by high school students with the support of OPERATION WIPE OUT partners and linked to school-based vaccination in a rural county that has the highest cervical cancer incidence in the state (Chambers County).
The specific aims are: (1) To develop and examine the feasibility of a theory-driven, participatory multi-channel communication campaign to promote HPV vaccination uptake with high school students being agents of change and provision of school-based vaccination; and (2) To examine specific features of the multi-channel communication campaign regarding scalability, sustainability, and potentially a future full-scale implementation science trial.
The primary outcome will be HPV vaccination uptake at the county level obtained Alabama Department of Public Health Vaccination Registry (ImmPRINT).
Additionally, treatment fidelity and scalability assessments will be conducted to inform sustainability efforts.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The human papillomavirus (HPV) is the most common sexually transmitted infection in the U.S., and it has been well established that high-risk HPV infection is causally related to cervical, vaginal, vulvar, anal, and oropharyngeal cancer.
This discovery led to the development of a safe and effective preventive vaccine that is available in U.S. through most health insurances or federally-funded programs.
The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination for all children and adults ages 9 to 26 in the U.S.
However, HPV vaccination rates nationally and in Alabama lag far behind the Healthy People 2020 goal of 80% coverage.
Despite multiple efforts, Alabama still ranks third in cervical cancer mortality and incidence nationally with great disparities within the state, particularly between urban and rural counties.
In order to address this public health challenge, organizations have come together to develop, implement, and evaluate a statewide action plan to eliminate cervical cancer as a public health problem in Alabama by 2033.
This plan was officially launched by the State Health Officer in May 2023 as a partnership between government, academia, civic organizations, and non-profit organizations and is known as OPERATION WIPE OUT.
While the plan is comprehensive and we have outlined specific evidence-based strategies to promote HPV vaccination along with cervical cancer screening/follow-up, the evidence on multi-channel communication interventions (besides provider-focused interventions) to promote HPV vaccination uptake at the population level is scarce, and the results are mixed.
The overall goal of this Supplement is to develop, implement, and examine the feasibility and scalability of a theory-driven, participatory multi-channel communication campaign to promote HPV vaccination uptake that is designed and delivered by high school students with the support of OPERATION WIPE OUT partners and linked to school-based vaccination in a rural county that has the highest cervical cancer incidence in the state (Chambers County).
Key components will include: (a) capacity building of high school students providing them with knowledge, skills, and support to develop and implement the campaign; (b) engagement of parents, teachers, school nurses, and school administrators); and (c) school-based vaccination.
The specific aims are: (1) To develop and examine the feasibility of a theory-driven, participatory multi-channel communication campaign to promote HPV vaccination uptake with high school students being agents of change and provision of school-based vaccination; and (2) To examine specific features of the multi-channel communication campaign regarding scalability, sustainability, and potentially a future full-scale implementation science trial.
The primary outcome will be HPV vaccination uptake at the county level.
Alabama has a robust vaccination registry managed by Alabama Department of Public Health (ImmPRINT).
Additionally, treatment fidelity and scalability assessments (acceptability, feasibility, potential reach and adoption, alignment with the strategic context) will be conducted to inform sustainability efforts.
Study Type
Interventional
Enrollment (Estimated)
29
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Isabel C Scarinci, PhD
- Phone Number: 2059757177
- Email: scarinci@uab.edu
Study Locations
-
-
Alabama
-
Lafayette, Alabama, United States, 36862
- Recruiting
- Chambers County School District
-
Contact:
- Jennifer Williams, RN
- Phone Number: 334-864-9343
- Email: williamsje@chambersk12.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- High school students enrolled in the Health Science Program at the Chambers County School District, Alabama
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: HPV vaccination
Multi-channel campaign to promote HPV vaccination
|
High school students will develop, implement, and evaluate a multi-channel communication campaign to promote HPV vaccination.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HPV Vaccination at the county level
Time Frame: One year
|
HPV vaccination uptake at the county level
|
One year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HPV vaccination at the school level
Time Frame: one year
|
HPV vaccination at the school level
|
one year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knowledge and confidence among the high school students
Time Frame: 6 months
|
Pre- and post-training level of knowledge and confidence among the high school students participating in the intervention
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Isabel Scarinci, PhD, University of Alabama at Birmingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 8, 2023
Primary Completion (Estimated)
July 31, 2024
Study Completion (Estimated)
August 31, 2024
Study Registration Dates
First Submitted
January 30, 2024
First Submitted That Met QC Criteria
January 30, 2024
First Posted (Actual)
February 7, 2024
Study Record Updates
Last Update Posted (Actual)
March 15, 2024
Last Update Submitted That Met QC Criteria
March 13, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB3000011735
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
We only have 12 students enrolled in the research and we need to keep confidentiality
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HPV Vaccination
-
Memorial Sloan Kettering Cancer CenterHackensack Meridian Health; The City College of New YorkActive, not recruitingHPV VaccinationUnited States
-
Yale UniversityNational Cancer Institute (NCI)Completed
-
Yasemin ATEŞEYANCompleted
-
University of Colorado, DenverUniversity of MichiganCompletedHPV Vaccination StatusUnited States
-
Xijing HospitalEnrolling by invitationHPV Vaccination、HPV Related Diseases、Protective EfficacyChina
-
University of Colorado, DenverUniversity of MichiganCompletedHPV Vaccination Decision QualityUnited States
-
The University of Texas Health Science Center,...CompletedIncrease HPV Vaccination Uptake | Delay Sexual DebutUnited States
-
University of RochesterCenters for Disease Control and PreventionCompletedIncrease in Use of Immunization Registry | Increase in HPV Vaccination RateUnited States
-
University of UtahNational Cancer Institute (NCI); Kaiser Permanente; University of Arizona; Sea...Not yet recruitingVaccine Hesitancy | HPV Vaccination | Vaccine Refusal | Vaccine; Uptake | Vaccination; Series CompletionUnited States
-
University Hospital, BrestCompletedCervical Cancer | Vaccine Preventable Disease | HPV | HPV Vaccination | Cervical LesionFrance